Total-body PET imaging market to hit $2.63 billion by 2030

The total-body positron emission tomography imaging market is projected to grow from $1.4 billion in 2025 to $2.63 billion by 2030, driven by rising cancer cases, broader use of advanced diagnostic systems and investment in imaging infrastructure. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Total-body PET imaging is becoming a bigger part of cancer diagnosis and treatment monitoring because it can scan the whole body in one session. - The market's growth signals rising demand for faster, more precise imaging as cancer and chronic disease rates climb. - The technology matters for hospitals and imaging centers investing in advanced diagnostic tools, especially where oncology volumes are rising.

What happened: - The total-body positron emission tomography imaging market is projected to increase from $1.4 billion in 2025 to $1.58 billion in 2026. - The market is forecast to reach $2.63 billion by 2030. - The 2025-2026 growth rate is 13.2%. - The 2026-2030 growth rate is projected at 13.5%. - The Business Research Company published the market outlook on July 22, 2026. - The report includes a free sample and a full version available through the company's announcement.

The details: - Cancer is the main growth driver behind demand for total-body PET imaging. - Total-body PET supports early detection of lesions, better metastasis identification and treatment-response monitoring. - The technique captures metabolic and physiological activity across the entire body in a single scan. - Radiotracers that emit gamma rays from positron decay enable highly sensitive visualization of biological processes. - The extended field of view and higher detection efficiency allow faster scans, better image quality and more accurate diagnoses than conventional PET imaging. - The report points to wider use of PET-CT hybrid systems, radiotracer-based diagnostics, AI-driven workflows and investments in hospital imaging infrastructure. - Emerging trends include AI-assisted PET reconstruction and interpretation, ultra-wide field-of-view systems, semiconductor-based detectors, PET-CT and PET-MRI hybrids, and cloud-based imaging data storage and analytics. - North America held the largest regional share in 2025. - Asia-Pacific is projected to be the fastest-growing region. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast reflects a shift from basic imaging capacity toward higher-performance systems that can support precision oncology and earlier intervention. - The emphasis on AI, hybrid imaging and cloud analytics suggests the market is moving toward more integrated diagnostic workflows, not just better scanners. - Regional growth expectations point to a mature U.S. and European base, with future expansion increasingly tied to healthcare investment in Asia-Pacific.

What's next: - Hospital systems and imaging providers are likely to keep investing in total-body PET capacity as oncology demand grows. - Adoption of AI-enabled reconstruction, hybrid imaging and advanced detectors may shape product development and purchasing decisions through 2030. - The report expects continued market support from research in molecular imaging and drug development, along with broader preventive screening and early detection efforts.